New search | Conferencedetail
Print view
 
 

Gene Therapy for Ophthalmic Disorders | August 5-6 - EDT | Online

Evvnt Promotion / evvnt
Archive
-
05.08.2020 - 06.08.2020  Online
Time: 09:00 to 17:30
 
Conference themes
More companies than ever before are realizing the potential of gene therapies to treat a wide range of ophthalmic disorders but in practice there are still hurdles to overcome.

A variety of unique challenges must be addressed to effectively bring gene therapies to patients, from developing preclinical models that accurately translate to the clinic to validating clinical endpoints that will satisfy regulators.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/645519-1?pid=4832

Speakers: Wiley Chambers, FDA, Thierry Bordet, Eyevensys, Dan Chung, Spark Therapeutics, Viral Kansara, Clearside Biomedical Inc., Brian Mansfield, Foundation for Fighting Blindness, and more.
 

Enquiries and Registration:

https://go.evvnt.com/645519-2?pid=4832
Mr. Customer Service
 
Categories
General Medicine
Languages
English
Congress fees
2 Day Digital Conference - Standard: USD 1999.00, 2 Day Digital Conference - Early Booking Rate: USD 1399.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Health Forum GasteinHilfswerk AustriaÖsterreichische Akademie der ÄrzteEuropean Public Health Association (EUPHA)Ärzte der WeltAMREF - African Medical and Research FoundationÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public Health